Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.54

+3.2%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (3747)	6/25/1997 7:36:00 AM
From: Henry Niman	of 32384

LGND's dip began on Friday and it was again on light volume (Tuesday's IBD still had an "A" accumulation rating). I had noted that before yesterday's slide. When volume declines, MMs frequently jerk around price to stimulate volume or pick up swaps. I was rather surprised at the jump in BMY's price. Taxol is very toxic and the approval was for second line (its used when first line treatment fails). There is no approved topical treatment. LGND's approach is to use natural products or derivatives and modify the cell's information system. Taxol and most other chemotherpeutic agents are generally killers that show some specificity for cancer cells. As far as diabeted is concerned, I suspect that clinical results and a mega deal will be announced at about the same time (3Q/4Q).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next